Meriem Lamghari, RESTORE project coordinator, has reactivated the working group on Regenerative Medicine after being appointed member of the executive board of European Technology Platform in Nanomedicine (ETPN).
The ETPN is an initiative led by industry since 2005 and set up together with the European Commission, to address the application of nanotechnology in healthcare, through the involvement of the relevant stakeholders across academia, SMEs, industry, public agencies, representatives from national platforms, among others. Acting as a think tank of nanomedicine in Europe and pushing forwards to become a driving force for industrialization, ETPN focuses their efforts on different working group aimed at enabling technologies and tackling translation issues.
The working group now led by Meriem Lamghari (INEB) and co-chaired by Lia Rimondini (UPO), focuses on regenerative medicines, which encompasses the processes of replacing, engineering, or regenerating human cells, tissues, or organs to restore or establish normal function. Within this working group, nanotechnologies and nanomaterials offer a wide range of new possibilities to optimize regenerative medicines; while nanoparticles and nanofibers may notably act as carriers, targeting elements and/or scaffolds in combination with biomaterials, to trigger better and faster replacement of damaged tissues and organs by stimulating the body’s own repair mechanisms.
With the reactivation of this working group, Meriem Lamghari intends to turn the Regenerative Medicines working group into a forum for free open dialogue and alliances between key stakeholders in the field of regenerative nanomedicine, stakeholders which share between them the interest of enabling the progress of this field and the implementation of regenerative therapies in society. The key actions of this working group are i) Dissemination of R&D of Regenerative medicine, ii) Surveys on trends in Regenerative medicine in Europe and iii) Mapping of R&D European collaborative projects on Regenerative Medicines.
To achieve these objectives, a series of webinars dedicated to Regenerative Medicine have been launched. We invite you to watch the replay of the webinar “Smart Materials & technologies in Regenerative medicine” which was organized on November 10, 2021.